Problems related to levodopa‐carbidopa intestinal gel treatment in advanced Parkinson's disease

BACKGROUND: Continuous levodopa‐carbidopa intestinal gel (LCIG) diminishes daily “off” time and dyskinesia in patients with advanced Parkinson′s disease (PD). Complications are common with percutaneous endoscopic gastrostomy with a jejunal extension tube (PEG‐J). AIM OF THE STUDY: To report the clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Udd, Marianne, Lyytinen, Jukka, Eerola‐Rautio, Johanna, Kenttämies, Anu, Lindström, Outi, Kylänpää, Leena, Pekkonen, Eero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516610/
https://www.ncbi.nlm.nih.gov/pubmed/28729942
http://dx.doi.org/10.1002/brb3.737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516610/
https://www.ncbi.nlm.nih.gov/pubmed/28729942
http://dx.doi.org/10.1002/brb3.737

Ejemplares similares